Central injections of arginine vasopressin prolong extinction of active avoidance
- 1 March 1986
- Vol. 7 (2) , 213-218
- https://doi.org/10.1016/0196-9781(86)90215-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Subcutaneous Administration of Behaviorally Effective Doses of Arginine Vasopressin Change Brain AVP Content Only in Median EminenceNeuroendocrinology, 1986
- Peripheral injections of vasopressin control behavior by way of interoceptive signals for hypertensionBehavioural Brain Research, 1985
- Localization and characterization of vasopressin-binding sites in the amygdala of the rat brainJournal of Neuroscience, 1984
- Central target for the behavioural effects of vasopressin neuropeptidesNature, 1984
- Vasopressin and oxytocin—their role in neurotransmissionPharmacology & Therapeutics, 1983
- A Major Metabolite of Arginine Vasopressin in the Brain Is a Highly Potent NeuropeptideScience, 1983
- Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processesBrain Research, 1978
- Design of potent antagonists of the vasopressor response to arginine-vasopressinJournal of Medicinal Chemistry, 1978
- Long Term Effect of Vasopressin on the Maintenance of a Conditioned Avoidance Response in RatsNature, 1971
- Multiple Range and Multiple F TestsPublished by JSTOR ,1955